Biopsy collection

PROCEDURE4 trials

Sponsors

Institut Paoli-Calmettes, Albert Einstein College of Medicine, Indiana University

Conditions

GliomaInflammatory Bowel DiseasesLocally Advanced Malignant NeoplasmLung Cancer MetastaticNon Hodgkin LymphomaPancreatic Adenocarcinoma MetastaticUrologic Neoplasms

Unknown Phase

Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy

CompletedNCT03595813

Institut Paoli-CalmettesLocally Advanced Malignant Neoplasm, Lung Cancer Metastatic, Non Hodgkin Lymphoma +1

Start: 2018-01-29End: 2025-06-25Updated: 2026-04-21

The Role of the Pregnane X Receptor (PXR) in Indole Signaling and Intestinal Permeability in Inflammatory Bowel Disease

CompletedNCT04089501

Albert Einstein College of MedicineInflammatory Bowel Diseases

Start: 2015-02-25End: 2019-05-02Updated: 2019-09-16

Registering Genomics and Imaging of Tumors (ReGIT)

RecruitingNCT05386043

Indiana UniversityGlioma

Start: 2023-07-18End: 2032-07-17Target: 20Updated: 2025-09-15

Metabolic Reprogramming and Microenvironment in Pancreatic Adenocarcinoma

RecruitingNCT07664891

Institut Paoli-CalmettesPancreatic Adenocarcinoma Metastatic

Start: 2025-09-11End: 2028-09-01Target: 64Updated: 2026-06-24

Related Papers

Soluble BTN2A1 as a potential predictive biomarker of immune checkpoint inhibitor efficacy in advanced non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology2020-05-201 citations